DOCSLIB.ORG

The State of Cancer Control in Australia 1987-2007: Changes in Cancer Incidence and Mortality 2 • the State of Cancer Control in Australia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The State of Cancer Control in Australia 1987-2007: Changes in Cancer Incidence and Mortality 2 • the State of Cancer Control in Australia The State of Cancer Control in Australia 1987-2007: Changes in cancer incidence and mortality 2 • The State of Cancer Control in Australia Cancer Council NSW November 2013 Authors Eleonora Feletto Alison Gibberd Clare Kahn Katie Armstrong Karen Canfell May Chiew Paul Grogan Carolyn Nickson Dianne O’Connell Andrew Penman Monica Robotin David P Smith Megan A Smith Rajah Supramaniam Louiza Velentzis Marianne Weber Xue Qin Yu Freddy Sitas Acknowledgments The authors would like to thank Mark Short at the Australian Institute of Health and Welfare and Julia Fitzgerald from the Australian Bureau of Statistics for compiling the tables for us, and for providing invaluable advice on ICD changes and conversion codes. We would also like to thank Priscilla Johnson, Associate Professor Peter Baade and Professor Bernard W Stewart for reviewing the document. ISBN 978-1-921619-95-3 Key words: Cancer control, Australia, neoplasms, incidence, mortality, cancer Suggested citation: Feletto E, Gibberd A, Kahn C, Armstrong K, Canfell K, Chiew M, Grogan P, Nickson C, O’Connell D, Penman A, Robotin M, Smith DP, Smith MA, Supramaniam R, Velentzis L, Weber MF, Yu XQ, Sitas F. The State of Cancer Control in Australia: 1987–2007: Changes in cancer incidence and mortality. Sydney: Cancer Council NSW; 2013. Published by Cancer Council NSW 2013 November, 2013 Table of Contents 1. Abbreviations 9 2. Report Overview 11 3. Executive Summary 13 3.1. Background 13 3.2. Aims 13 3.3. Methods 14 3.4. Results 14 3.4.1. Breast cancer 14 3.4.2. Cervical cancer 14 3.4.3. Colorectal cancer 15 3.4.4. Liver cancer 15 3.4.5. Lung cancer 15 3.4.6. Melanoma 15 3.4.7. Prostate cancer 16 3.4.8. Stomach cancer 16 3.4.9. Australian approach to health care and cancer control 16 3.5. Discussion 17 3.6. Conclusion 17 4. Introduction 21 5. Methods 25 5.1. Incidence and mortality changes 25 5.2. National policy development 26 6. Results: analysis of findings overall – incidence and mortality 29 6.1. Changes in mortality 29 6.2. Changes in incident cases 30 6.3. Overall changes 34 7. Results: analysis of cancer types - incidence and mortality 37 7.1. Breast cancer (C50) 39 7.1.1. Background 39 7.1.2. Incidence and mortality rates in Australia, 1987–2007 42 7.2. Cervical cancer (C53) 44 7.2.1. Background 44 7.2.2. Incidence and mortality rates in Australia, 1987–2007 49 7.3. Colorectal cancer (C18–C20) 55 Cancer Council NSW • 3 4 • The State of Cancer Control in Australia 7.3.1. Background 55 7.3.2. Incidence and mortality rates in Australia, 1987–2007 58 7.4. Liver cancer (C22) 63 7.4.1. Background 63 7.4.2. Incidence and mortality rates in Australia, 1987–2007 65 7.5. Lung cancer (C33–C34) 68 7.5.1. Background 68 7.5.2. Incidence and mortality rates in Australia, 1987–2007 72 7.6. Melanoma (C43) 77 7.6.1. Background 77 7.6.2. Incidence and mortality rates in Australia, 1987–2007 79 7.7. Prostate cancer (C61) 83 7.7.1. Background 83 7.7.2. Incidence and mortality rates in Australia, 1987–2007 85 7.8. Stomach cancer (C16) 89 7.8.1. Background 89 7.8.2. Incidence and mortality rates in Australia, 1987–2007 91 8. Cancer control policies, programs and emerging issues 95 8.1. Cancer as a non-communicable disease and cancer control 95 8.2. Cancer control globally 96 8.2.1. Role of NGOs 97 8.3. Australian approach to cancer control 98 8.3.1. Health care in Australia 98 8.3.2. Evolution of cancer control and related policies in Australia 99 8.3.3. Government agencies 102 8.3.4. Australian cancer control policy 102 8.3.5. Existing cancer control–related programs and initiatives 103 8.3.6. Cancer control data sources: monitoring of trends 110 8.4. Cancer control in practice 111 8.4.1. Cancer care: key elements and emerging issues 111 8.4.2. Discovery and advancement in prevention, diagnosis and treatment 113 8.4.3. Cancer control implementation process and leadership 114 8.5. Summary of cancer control policies, programs and emerging issues 116 November, 2013 9. Discussion and future research 127 9.1. Burden of early diagnosis 128 9.2. Health records 128 9.3. Implications for the ageing population 128 9.4. Focus on prevention 129 9.5. Evidence-based interventions and government decision-making 129 9.6. Dilemmas in cancer control 129 9.7. Future research 130 10. Conclusion 133 11. References 135 Cancer Council NSW • 5 6 • The State of Cancer Control in Australia Figures Figure 6–1 Age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 30 Figure 6–2 Age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 31 Figure 6–3 Change in cancer incident cases and mortality in Australia from 1987–2007 – MALES 34 Figure 6–4 Change in cancer incident cases and mortality in Australia from 1987–2007 – FEMALES 35 Figure 6–5 Change in cancer incident cases and mortality in Australia from 1987–2007 – PERSONS 36 Figure 7–1 Breast cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 42 Figure 7–2 Breast cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 42 Figure 7–3 Cervical cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 50 Figure 7–4 Cervical cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0– 74 years 50 Figure 7–5 Colorectal cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 58 Figure 7–6 Colorectal cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 58 Figure 7–7 Liver cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 66 Figure 7–8 Liver cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 66 Figure 7–9 Lung cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 72 Figure 7–10 Lung cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 72 Figure 7–11 Melanoma: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 80 Figure 7–12 Melanoma: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 80 Figure 7–13 Prostate cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 86 Figure 7–14 Prostate cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 86 Figure 7–15 Stomach cancer: age-standardised cancer mortality rates in Australia 1987–2007, 0–74 years 92 Figure 7–16 Stomach cancer: age-standardised cancer incidence rates in Australia 1987–2007, 0–74 years 92 Figure 8–1 Australian Government and preventive health structure 99 November, 2013 Figure 8–2 Cancer control implementation process 115 Tables Table 6–1 Mortality: number of observed deaths in Australia in 2007 compared to expected number of deaths based on 1987 rates 32 Table 6–2 Incidence: number of observed new cases in Australia in 2007 compared to expected number of new cases based on 1987 rates 33 Table 7–1 Breast cancer deaths and incident cases in Australia 1987–2007 42 Table 7–2 Breast cancer: average annual percentage change (AAPC) 42 Table 7–3 Cervical cancer deaths and incident cases in Australia 1987–2007 50 Table 7–4 Cervical cancer: average annual percentage change (AAPC) 50 Table 7–5 Colorectal cancer deaths and incident cases in Australia 1987–2007 58 Table 7–6 Colorectal cancer: average annual percentage change (AAPC) 58 Table 7–7 Liver cancer deaths and incident cases in Australia 1987–2007 66 Table 7–8 Liver cancer: average annual percentage change (AAPC) 66 Table 7–9 Lung cancer deaths and incident cases in Australia 1987–2007 72 Table 7–10 Lung cancer: average annual percentage change (AAPC) 72 Table 7–11 Melanoma deaths and incident cases in Australia 1987–2007 80 Table 7–12 Melanoma: average annual percentage change (AAPC) 80 Table 7–13 Prostate cancer deaths and incident cases in Australia 1987–2007 86 Table 7–14 Prostate cancer: average annual percentage change (AAPC) 86 Table 7–15 Stomach cancer deaths and incident cases in Australia 1987–2007 92 Table 7–16 Stomach cancer: average annual percentage change (AAPC) 92 Table 8–1 Key health policies and strategies relating to cancer control 101 Cancer Council NSW • 7 8 • The State of Cancer Control in Australia November, 2013 November, 2013 1 Abbreviations Abbreviations APC Annual percentage change AAPC Average annual percentage change ABS Australian Bureau of Statistics AHMAC Australian Health Ministers Advisory Council AIHW Australian Institute of Health and Welfare BMI Body mass index DoHA Australian Government Department of Health and Ageing DRE Digital rectal examination NPAPH National Partnership Agreement on EPIC European Prospective Investigation into Cancer Preventive Health and Nutrition NPHP National Public Health Partnership FOBT Faecal occult blood test NSIF National Service Improvement Framework HIV - 1 Human immunodeficiency virus 1 NSW New South Wales HPV Human papillomavirus PBS Pharmaceutical Benefits Scheme HRT Hormone replacement therapy PSA Prostate-specific antigen HWA Health Workforce Australia RFA Radiofrequency ablation IARC International Agency for Research on Cancer SES Socioeconomic status MBS Medicare Benefits Scheme UICC Union for International Cancer Control NCD Non-communicable diseases UK United Kingdom NGO Non-government organisation USA United States of America NHMRC National Health and Medical Research Council WHO World Health Organization NHRA National Health Reform Agreement Cancer Council NSW • 9 10 • The State of Cancer Control in Australia November, 2013 November, 2013 2 Report overview Cancer is currently the largest disease burden in Australia and is growing in incidence, primarily due to an ageing population.1-3 The aim of this report is to quantify the changes in cancer incidence and mortality from 1987 to 2007, thus providing a simple summary of the progress over two decades.
Load more

Recommended publications
  • Is the Risk of Cancer in Australia Overstated? the Importance of Competing Mortality for Estimating Lifetime Risk
    Research Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk Anthea C Bach1,2,* , Kelvin SE Lo2,3,*, Thanya Pathirana4,5, Paul P Glasziou5 , Alexandra L Barratt6, Mark A Jones5,7, Katy JL Bell6 Abstract The known: The Australian Institute of Health and Welfare (AIHW), like many cancer registries, calculates cumulative risk Objectives: To calculate lifetime risks of cancer diagnosis and from cross- sectional data to estimate lifetime risks of cancer cancer- specific death, adjusted for competing mortality, and to diagnosis and mortality. Its method assumes there are no compare these estimates with the corresponding risks published by competing causes of death, which may lead to overestimation of the Australian Institute of Health and Welfare (AIHW). lifetime risk. Design, setting: Analysis of publicly available annual AIHW data The new: Adjusting for competing mortality reduced the on age- specific cancer incidence and mortality — for breast cancer, estimated lifetime risks of cancer diagnosis and cancer- specific colorectal cancer, prostate cancer, melanoma of the skin, and lung mortality for the five most common cancers in Australia. cancer — and all- cause mortality in Australia, 1982–2013. The implication: Estimates of cancer- specific risk are widely Outcome measures: Lifetime risks of cancer diagnosis and circulated in awareness campaigns and for promoting early mortality (to age 85), adjusted for competing mortality. detection activities. Adjusted estimates would be more appropriate Results: During 1982–2013, AIHW estimates were consistently for informing choices by individuals. higher than our competing mortality- adjusted estimates of lifetime risks of diagnosis and death for all five cancers.
    [Show full text]
  • Lung Cancer Screening Enquiry – Consultation Paper
    Lung Cancer Screening enquiry – consultation paper On 1 August 2019, the Minister for Health, the Hon. Greg Hunt MP, invited Cancer Australia to conduct an enquiry into the prospects, process and delivery of a national lung cancer screening program for people at high risk of lung cancer in Australia. Cancer Australia is seeking input and submissions from all Australians with an interest in lung cancer to help inform the enquiry. Consultation paper This consultation paper is for stakeholders who wish to provide input to the Lung Cancer Screening enquiry (the enquiry) through the Lung Cancer Screening enquiry Consultation Hub. It includes information about why the enquiry is being held, describes the policy context and provides an overview of the proposed approach to the enquiry and the issues under consideration in design of a possible national lung cancer screening program for Australia. Why is the enquiry being held? The enquiry is being held to investigate the feasibility of a national lung cancer screening program for people at high risk of lung cancer in Australia. Cancer Australia will submit a report to the Minister for Health on the prospects, process and delivery of such a program. The enquiry recognises the need for continuing effort to reduce deaths from lung cancer in Australia. Lung Lung cancer in Australia cancer is a common cancer in Australian men and • In 2019, 12,817 people are women and the leading cause of cancer-related estimated to be diagnosed with deaths in Australia. lung cancer in Australia (8.9% of all new cancer cases) More than half of all cases of lung cancer are • In 2019, 9,034 people are diagnosed at an advanced stage, when the likelihood estimated to die from lung of effective treatment is lower.
    [Show full text]
  • Lung Cancer in Queensland, 1982 to 2004
    Current status of lung cancer in Queensland, 1982 to 2004 December 2007 Viertel Centre for Research in Cancer Control Accredited by the NHMRC as an independent research institute The generosity of the Queensland community and the Sylvia and Charles Viertel Charitable Foundation makes our research possible We are an independent, community-based charity and are not government funded Current status of lung cancer in Queensland, 1982 to 2004 The Cancer Council Queensland Current status of lung cancer in Queensland, 1982 to 2004 December 2007 Viertel Centre for Research in Cancer Control The Cancer Council Queensland Current status of lung cancer in Queensland, 1982 to 2004 The Cancer Council Queensland Viertel Centre for Research in Cancer Control Executive Summary The Cancer Council Queensland 553 Gregory Terrace The Cancer Council Queensland is dedicated to eliminating cancer and diminishing suffering from Fortitude Valley QUEENSLAND 4006 cancer through research, treatment, patient care and prevention and early detection.1 Part of this AUSTRALIA commitment includes informing Queenslanders of the latest available data on cancer. Postal Address: This report is the second in a series (following an earlier publication on prostate cancer),2 and PO Box 201 contains a comprehensive description of lung cancer incidence, mortality, survival and prevalence Spring Hill QUEENSLAND 4004 in Queensland utilising the most recent information released by the Queensland Cancer Registry. AUSTRALIA Comparisons are also made against Australian and international results where applicable. Telephone: +61 7 3258 2309 Comment boxes appear throughout the report. These comments have been included to expand Facsimile: +61 7 3258 2310 on the statistical information that has been presented and to provide more detailed information on Email: [email protected] recently published research into lung cancer epidemiology and the effects of smoking.
    [Show full text]
  • Enquiry Report on the Lung Cancer Screening Enquiry Report on the Lung Cancer Screening Enquiry
    REPORT ON THE LUNG CANCER SCREENING ENQUIRY REPORT ON THE LUNG CANCER SCREENING ENQUIRY REPORT ON THE LUNG CANCER SCREENING ENQUIRY Report on the Lung Cancer Screening Enquiry was prepared and produced by: Cancer Australia Locked Bag 3 Strawberry Hills NSW 2012 Australia Freecall 1800 624 973 +61 2 9357 9400 canceraustralia.gov.au © Cancer Australia 2020. ISBN Print: 978-1-74127-355-7 ISBN Online: 978-1-74127-356-4 Recommended citation Cancer Australia, 2020. Report on the Lung Cancer Screening Enquiry, Cancer Australia, Surry Hills, NSW. Copyright statements Paper-based publications This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from Cancer Australia to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Publications and Copyright contact officer, Cancer Australia, Locked Bag 3, Strawberry Hills, NSW 2012. Internet sites This work is copyright. You may download, display, print and reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction.
    [Show full text]
  • Cancer in Australia 2000 (Full Publication) (AIHW)
    Cancer in Australia 2000 The Australian Institute of Health and Welfare is Australia’s national health and welfare statistics and information agency. The Institute’s mission is Better health and wellbeing for Australians through better health and welfare statistics and information. The Australasian Association of Cancer Registries (AACR) is a collaborative body representing state and territory cancer registries in Australia and New Zealand. Most are members of the International Association of Cancer Registries. The AACR was formed in November 1982 to provide a formal mechanism for promoting uniformity of collection, classification and collation of cancer data. The purposes of the AACR are: S to provide a continuing framework for the development of population-based cancer registration in Australia and New Zealand; S to facilitate the exchange of scientific and technical information between cancer registries and to promote standardisation in the collection and classification of cancer data; S to facilitate cancer research both nationally and internationally; and S to facilitate the dissemination of cancer information. The Australian Institute of Health and Welfare has joined with the AACR to produce national cancer statistics from the National Cancer Statistics Clearing House. CANCER SERIES Number 23 Cancer in Australia 2000 November 2003 Australian Institute of Health and Welfare Australasian Association of Cancer Registries Canberra AIHW cat. no. CAN 18 © Australian Institute of Health and Welfare 2003 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced without prior written permission from the Australian Institute of Health and Welfare. Requests and enquiries concerning reproduction and rights should be directed to the Head, Media and Publishing Unit, Australian Institute of Health and Welfare, GPO Box 570, Canberra ACT 2601.
    [Show full text]
  • Report on Lung Cancer in Australia Literature Review and Consultation
    REPORT ON LUNG CANCER IN AUSTRALIA LITERATURE REVIEW AND CONSULTATION ON FACTORS IMPACTING ON LUNG CANCER OUTCOMES This project is an initiative of Cancer Australia’s National Lung Cancer Program funded by the Australian Government. The report was prepared by Curtin University. Report on Lung Cancer in Australia. Literature review and consultation on factors impacting on lung cancer outcomes ISBN: 978-1-74241-375-4 Online ISBN: 978-1-74241-376-1 Publications Number: D0161 Copyright Statements: Paper-based publications © Commonwealth of Australia 2011 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney-General’s Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca Internet sites © Commonwealth of Australia 2011 This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from any use as permitted under the Copyright Act 1968, all other rights are reserved. Requests and inquiries concerning reproduction and rights should be addressed to Commonwealth Copyright Administration, Attorney-General’s Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca
    [Show full text]
  • Risk Factors for Lung Cancer
    Risk factors for lung cancer An overview of the evidence 2014 Risk factors for lung cancer: an overview of the evidence was prepared and produced by: Cancer Australia Locked Bag 3 Strawberry Hills NSW 2012 Australia Tel: +61 2 9357 9400 Fax: +61 2 9357 9477 canceraustralia.gov.au © Cancer Australia 2014. Published with minor amendments. ISBN Print: 978-1-74127-269-7 ISBN Online: 978-1-74127-262-8 Recommended citation Cancer Australia, 2014. Risk factors for lung cancer: an overview of the evidence, Cancer Australia, Surry Hills, NSW. Risk factors for lung cancer: an overview of the evidence can be downloaded from the Cancer Australia website: canceraustralia.gov.au or ordered by telephone: 1800 624 973. Copyright statements Paper-based publications This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from Cancer Australia to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Publications and Copyright contact officer, Cancer Australia, Locked Bag 3, Strawberry Hills, NSW 2012.
    [Show full text]
  • Lung Cancer Australian Study PEEK Volume 1 Issue 8, January 2019
    2018 TIONS TA TIENT KNOWLEDGE PA EXPEC EXPERIENCE PEwww.cc-dr.orgE K Lung cancer Australian Study PEEK Volume 1 Issue 8, January 2019 1 This study was generously sponsored by AstraZeneca Australia. AstraZeneca provided arm’s length sponsorship for the Centre for Community-Driven Research to implement the PEEK protocol in bladder cancer. The sponsor had no input into the methodology, data collection, data analysis of reporting. The International Centre for Community-Driven Research team for this study included: Catherine Holliday Anne Holliday Josephine Byrne Hunter Baggen Vanessa Brunelli Jill Wilson Katriona Smith Daniel Martino-Burke CCDR would like to thank each and every person that participated in this PEEK study. A special thank you also to our study partners Love and Light Support Group, Changing Lung Cancer, Love our Lungs and Lung Foundation Australia. We dedicate this PEEK study in lung cancer to Belinda Jones and Jay Silva. 2 Contents Summary of Results 4 Section 1: Introduction and methodology 29 Section 2: Demographics 38 Section 3: Symptoms and diagnosis 85 Section 4: Decision-making 111 Section 5: Treatment 126 Section 6: Communication and information 171 Section 7: Care and support 221 Section 8: Quality of life and experience in the health system 248 Section 9: Expectations and Messages 275 Section 10: Advice 300 Section 11: Discussion 307 Section 12: What’s next? 322 3 Summary Summary Lung Cancer 2018 Australian PEEK Study Summary Executive summary Characterisation of this study population: In this PEEK study, more women than men participated. There was an even number of participants with a high school or trade education compared with a university education and at ratio of 5:3 in relation to participants from a higher socioeconomic group compared to a lower socio-economic group.
    [Show full text]
  • Lung Cancer in Queensland an Overview 2012
    Lung Cancer in Queensland An Overview 2012 Acknowledgements The authors acknowledge and appreciate the work of Queensland Health staff who contribute to and participate in the development and maintenance of Queensland Oncology Repository, Queensland Oncology Online and the Oncology Analysis System which supports the collection, analysis and interpretation of cancer information in Queensland. The report was prepared by Michael Blake, Shoni Colquist, Danica Cossio, Tracey Guan, Hazel Harden and Dannie Zarate. We also wish to thank Associate Professor Rayleen Bowman and Professor Kwun Fong for reviewing the report and providing valuable comments. For more information: Queensland Cancer Control Analysis Team Queensland Health GPO Box 48 Brisbane, Queensland, 4001 Australia Ph: +61 (07) 3239 0886 Fax: +61 (07) 3239 0930 Email: [email protected] https://qccat.health.qld.gov.au Lung Cancer in Queensland: An Overview 2012 Suggested citation: Queensland Government. Lung Cancer in Queensland: An overview 2012. Queensland Health, Brisbane, 2012 Copyright protects this publication. However, the Queensland Government has no objection to this material being reproduced with acknowledgement, except for commercial purposes. Permission to reproduce for commercial purposes should be sought from: The Manager Queensland Cancer Control Analysis Team Queensland Health GPO Box 48 Brisbane, Queensland, 4001 Australia ISBN: 978-1-921707-91-9 Published by Queensland Health November 2012 ©The State of Queensland, Queensland Health 2012 Table of Contents Foreword..............................................................................................................................................................................
    [Show full text]
  • The Association Between Air Pollution and Lung Cancer in the North West of Adelaide
    The association between air pollution and lung cancer in the North West of Adelaide: a case control study and air quality monitoring Melissa Jayne Whitrow Department of Medicine and Department of Public Health Faculty of Health Science The University of Adelaide July 2004 Table of Contents 1. Chapter 1 Introduction..............................................................................................25 1.1. Lung Cancer...........................................................................................................29 1.1.1. Lung Cancer Demographics...........................................................................29 1.1.2. Lung Cancer in Australia...............................................................................33 1.1.3. Aetiology........................................................................................................37 1.2. North Western Metropolitan Adelaide................................................................38 1.2.1. Lung Cancer in the North West......................................................................40 1.2.2. Industry in the North West.............................................................................40 1.2.3. Ambient Air Quality in the NW.....................................................................49 2. Chapter 2 Review of the Literature..........................................................................51 2.1. Lung Cancer Histology..........................................................................................52 2.1.1.
    [Show full text]
  • Lung Cancer Screening Feasibility In'australia
    Luton, UK. 6Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, UK. 7Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust, King’s Lynn, UK. 8James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK. 9Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. 10West Suffolk Hospitals NHS Foundation Trust, Bury St Edmunds, UK. 11Mid Essex Hospital Services NHS Trust, Chelmsford, UK. 12MRC Biostatistics Unit, Institute of Public Health, University of Cambridge, Cambridge, UK. 13These authors contributed equally. Correspondence: Stefan J. Marciniak, Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, UK. E-mail: [email protected] Received: June 27 2014 | Accepted after revision: Feb 03 2015 | First published online: March 18 2015 Support statement: The study was funded by the East Anglian Thoracic Society. M.Z. Nikolić is a Wellcome Trust PhD Programme for Clinicians Fellow at the University of Cambridge. S.J. Marciniak is a Medical Research Council Senior Clinical Fellow. J. Wason is funded by the Cambridge Biomedical Research Centre. Funding information for this article has been deposited with FundRef. Conflict of interest: None declared. References 1 Gupta D, Hansell A, Nichols T, et al. Epidemiology of pneumothorax in England. Thorax 2000; 55: 666–671. 2 Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119: 590–602. 3 MacDuff A, Arnold A, Harvey J, et al. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: Suppl. 2, ii18–ii31. 4 Kelly AM, Druda D. Comparison of size classification of primary spontaneous pneumothorax by three international guidelines: a case for international consensus? Respir Med 2008; 102: 1830–1832.
    [Show full text]
  • National Asbestos Profile for Australia NOVEMBER 2017
    National Asbestos Profile for Australia NOVEMBER 2017 Asbestos Safety and Eradication Agency Report – 11-2017 This report has been prepared by the Asbestos Safety and Eradication Agency. The Asbestos Safety and Eradication Agency (ASEA) would like to acknowledge the contributions of members of its Technical Research Advisory Committee, Julia Collins, Professor and Director Ken Takahashi of the Asbestos Diseases Research Institute (ADRI), Safe Work Australia, Department of Immigration and Border Protection (DIBP), the enHealth Committee, iCare Dust Diseases Care (NSW) and state and territory work health and safety (WHS) regulatory bodies. 2 Contents Introduction 6 1. Current regulations on the different forms of asbestos 8 2. Import and consumption of asbestos each year 14 3. Importation of goods containing asbestos 17 4. Domestic production of asbestos 20 5. Domestic production of asbestos-containing materials 22 6. Estimated total number of workers exposed to asbestos in Australia 23 7. Industries where exposure to asbestos is present in Australia those with the largest numbers of workers potentially exposed to asbestos 25 8. Industries exceeding occupational exposure limits and estimated total number of workers at high risk 27 9. Estimate of the burden of asbestos-related diseases: disability adjusted life years and deaths attributable to asbestos exposure 29 10. Prevalence of asbestosis 32 11. Incidence of lung cancer among workers exposed to asbestos 34 12. Incidence of mesothelioma 35 13. Estimates on the percentage of house stock and vehicle fleet containing asbestos 37 14 Total number of workers eligible for compensation for asbestos-related diseases per year and the numbers of individuals compensated yearly 40 15.
    [Show full text]